Ó£ÌÒÊÓƵ

Lead candidate is encapsulated allogeneic txHepatocytes for treatment of acute liver failure, SAB expanded to include 3 global exp...

Ó£ÌÒÊÓƵ launches first product in groundbreaking ioCRISPR-Ready Cellsâ„¢ product range, paving the way for new advances in disease m...

WIRED have named 16 Trailblazer companies in Cambridge that are pushing boundaries and scaling up - including Ó£ÌÒÊÓƵ. 

Authority Magazine interviewed Ó£ÌÒÊÓƵ's SVP of tech ops and manufacturing Kathryn Golden to discover her path to leadership and w...

Our President and COO Kathryn Corzo talks with editor Brian Buntz from Drug Discovery & Development.

Partnership to build a platform for the development of safer and more efficient genetic engineering of human cells for cell therap...

New iPSC-derived opti-oxâ„¢ powered disease model cells with the potential to advance frontotemporal dementia research and drug disc...

Ó£ÌÒÊÓƵ received a gold award for its participation in the Green Impact awards for sustainability.